cytarabine and Intestinal Diseases

cytarabine has been researched along with Intestinal Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barber, L; Clay, J; Devlia, V; Feliu, J; Mufti, G; Pagliuca, A; Raj, K; Shaw, B1
Chondropoulos, S; Dervenoulas, J; Economopoulos, T; Giannopoulou, V; Girkas, K; Ioannidou, E; Kalli, T; Ladas, SD; Papageorgiou, E; Papaxoinis, G; Pappa, V; Triantafyllou, K; Tsirigotis, P1
Andretta, C; Camera, A; Ciancia, R; Della Cioppa, P; Picardi, M; Rinaldi, CR; Rossi, M; Rotoli, B; Selleri, C; Villa, MR; Volpicelli, M1
Baylin, SB; Burke, PJ; Luk, GD; Vaughan, WP1
Alvarez-Leite, JI; Bambirra, EA; Cara, DC; Ramos, MG; Vieira, EC1
Alvarez-Leite, J; Bambirra, EA; Cara, DC; Nicoli, JR; Ramos, MG; Vieira, EC1
Dubbs, DR; Frearson, PM; Kit, S; Melnick, JL1
Diluiso, G; Farber, E; Verbin, RS1

Other Studies

8 other study(ies) available for cytarabine and Intestinal Diseases

ArticleYear
Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies.
    British journal of haematology, 2014, Volume: 167, Issue:3

    Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cytarabine; Daunorubicin; Drug Therapy, Combination; Egg Hypersensitivity; Etoposide; Female; Food Hypersensitivity; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Intestinal Diseases; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Nut Hypersensitivity; Seafood; Tacrolimus; Transplantation Conditioning; Vidarabine

2014
Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.
    Bone marrow transplantation, 2008, Volume: 42, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capsule Endoscopy; Carmustine; Cytarabine; Female; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Diseases; Male; Melphalan; Middle Aged; Mucositis; Podophyllotoxin; Transplantation, Autologous

2008
Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.
    The hematology journal : the official journal of the European Haematology Association, 2003, Volume: 4, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Enterocolitis, Necrotizing; Female; Humans; Infusions, Parenteral; Injections, Subcutaneous; Intestinal Diseases; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Remission Induction; Retrospective Studies; Thrombocytopenia

2003
Diamine oxidase as a plasma marker of rat intestinal mucosal injury and regeneration after administration of 1-beta-D-arabinofuranosylcytosine.
    Cancer research, 1981, Volume: 41, Issue:6

    Topics: Alkaline Phosphatase; alpha-Glucosidases; Amine Oxidase (Copper-Containing); Animals; Cytarabine; Disaccharidases; Female; Humans; Injections, Subcutaneous; Intestinal Diseases; Intestinal Mucosa; Leukemia; Rats; Regeneration; Time Factors

1981
Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets.
    Nutrition and cancer, 1997, Volume: 28, Issue:2

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Cohort Studies; Cytarabine; Diet; Fatty Acids, Volatile; Inflammation; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Mice; Nucleotides

1997
Protection by short-chain fatty acids against 1-beta-D-arabinofuranosylcytosine-induced intestinal lesions in germfree mice.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Administration, Oral; Animals; Cytarabine; Disease Models, Animal; Fatty Acids, Volatile; Fatty Liver; Intestinal Diseases; Intestinal Mucosa; Mice; Protective Agents

1999
Enzyme induction in SV40-infected green monkey kidney cultures.
    Virology, 1966, Volume: 29, Issue:1

    Topics: Adenine Nucleotides; Autoradiography; Bromodeoxyuridine; Cycloheximide; Cytarabine; Deoxyuridine; DNA; DNA, Viral; Enzymes; In Vitro Techniques; Intestinal Diseases; Kinetics; Ligases; Protein Biosynthesis; Simian virus 40; Thymidine Kinase; Tritium

1966
Protective effects of cycloheximide against 1-beta-D-arabinosylcytosine-induced intestinal lesions.
    Cancer research, 1973, Volume: 33, Issue:9

    Topics: Animals; Cell Nucleus; Cycloheximide; Cytarabine; Epithelium; Intestinal Diseases; Intestinal Mucosa; Intestines; Lymphocytes; Male; Microscopy, Electron; Rats

1973